Study on adding albumin to diuretics for cirrhosis fluid retention halted early
NCT ID NCT04216784
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study aimed to see if adding albumin to the diuretic furosemide helps people with cirrhosis lose excess fluid better than furosemide alone. The trial planned to enroll 21 adults with cirrhosis and fluid buildup. However, it was terminated early due to funding problems, and no patient data was collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
furosemide and albumin
What this could lead to
If it had succeeded, this could have shown whether adding albumin to standard diuretics helps remove excess fluid more effectively in people with cirrhosis.
What could go wrong
The trial was terminated early before any data was collected, so no conclusions can be drawn. The combination is already controversial and not proven to work.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rush University Medical Center
Chicago, Illinois, 60612, United States